Together with our previous data that showed in the absence of BIM, NK cell anti-tumor function does not appear to benefit from increased survival, these data suggest that the failure to outcompete WT NK cells in the tumor setting does not compromise the anti-tumor function of Cish-deficient NK cells and highlight their increased cytotoxicity on a per cell basis. Here, BCL2L11 is linked to neoplasm.